[Producing evidence for all: geriatric oncology and the challenge of equity in health care].

Authors

Lynda Sifer-Rivière

Published in

La Revue du praticien. Volume 76. Issue 7. Pages 715-718.

Abstract

In France, nearly one third of breast cancers occur after the age of 70, yet these patients have long been underrepresented in the clinical trials that inform treatment decisions. This exclusion, rarely made explicit, became embedded in clinical practice. The ASTER 70s trial, published in The Lancet in 2025, provides new evidence. It shows that adjuvant chemotherapy does not improve overall survival in women aged 70 and older, while exposing them to significant toxicity and potential loss of autonomy. This seemingly negative result constitutes a decisive finding: it demonstrates that it is both possible and necessary to generate evidence for populations long excluded from clinical research. It calls for a rethinking of health equity.

PMID:
42808620
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.